DGM
DGM is the largest German self-help organization for people with neuromuscular diseases, operating 16 regional state associations, 12+ diagnosis-specific groups, and 100+ local support circles from its Freiburg headquarters. It provides counseling, peer support, professional training, and research funding funded by memberships, donations, event fees, and pharmaceutical sponsorship.
- Company typePrivate
- Founded2004
- HeadquartersFreiburg, Germany
- Headcount11–50
- GTM typeB2C
- OfferingServices
What DGM does
Deutsche Gesellschaft für Muskelkranke e.V. (DGM) is a German nonprofit self-help organization (eingetragener Verein) headquartered at Im Moos 4 in Freiburg, operating as the largest patient advocacy body in Germany for individuals affected by neuromuscular diseases. Founded in 2004 and serving a population of more than 100,000 affected people, DGM delivers services through a federated structure consisting of a federal headquarters, 16 regional state associations (Landesverbände) covering every Bundesland, 12+ diagnosis-specific groups covering conditions including ALS, SMA, DMD/BMD, CMT/HMSN, FSHD, and others, and over 100 local discussion circles and self-help groups (Gesprächskreise).
The organization's product portfolio centers on patient and family support — social and assistive-device counseling, the Patientenlotse (patient navigation guide), the online DGM-Forum for peer exchange, and family-focused programs including the JungeDGM youth division — alongside knowledge dissemination and research funding via the DGM Kongress, dedicated Patiententage, the Forschungspreise portfolio (Duchenne-Erb, Felix-Jerusalem, Junior, Myositis-Nachwuchs, FSHD-Ulrich-Brodeßer), and a quarterly newsletter. Underlying technology is a Drupal-based website hosted on Hetzner with a CRM developed and maintained by Ecoplan GmbH under GDPR data-processing terms, a twingle GmbH donation platform with PayPal payment integration, and social media presence across YouTube, Facebook, and Instagram.
DGM is funded primarily through membership dues, individual and commemorative donations, gift and corporate giving, public Gemeinschaftsförderung, modest e-commerce sales via the DGM Shop, and tiered event participation fees — for example, the SMA-Symposium 2026 charges €125 for members and €175 for non-members, the Col-VI-MD-Fachtagung 2026 charges €125-€190, and DGM THERAPIEWISSEN KOMPAKT seminars charge €20-€40. Go-to-market is community-led: membership is acquired via website, word-of-mouth, healthcare-provider referrals, and presence at neuromuscular centers, with flagship events sponsored by pharmaceutical partners including Biogen, Novartis, Roche, and Scholar Rock for SMA-related programming. Revenue is not publicly disclosed.
DGM firmographics
Firmographics- Name
- DGM
- Legal name
- Deutsche Gesellschaft für Muskelkranke e.V.
- Website
- https://dgm.org
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DGM is the largest German self-help organization for people with neuromuscular diseases, operating 16 regional state associations, 12+ diagnosis-specific groups, and 100+ local support circles from its Freiburg headquarters. It provides counseling, peer support, professional training, and research funding funded by memberships, donations, event fees, and pharmaceutical sponsorship.
- Ownership category
- akta.pro rank
DGM industry classification
Industry- Product category
- Patient Advocacy and Self-Help Services
- NAICS
- Voluntary Health Organizations (813212), Civic and Social Organizations (813410), Other Individual and Family Services (624190)
- SIC
- Services-Social Services (8300), Services-Membership Organizations (8600), Services-Health Services (8000)
- akta.pro primary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
Keywords
Where DGM is headquartered
LocationHeadquarters
- HQ city
- Freiburg
- HQ country
- Germany
- HQ region
- Europe
Offices5 records
Markets served
DGM business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- Membership dues: DGM generates revenue through annual membership fees from individuals with neuromuscular diseases and their family members. Membership provides access to counseling, support groups, conferences, and the organization's resources.
- Donations and charitable contributions: The organization receives donations from individuals, commemorative donations (Spenden im Trauerfall), special occasion donations, gift donations (Geschenkspende), and corporate partnerships. Donations are processed through the twingle GmbH platform and PayPal.
- Shop sales: DGM operates an e-commerce shop selling greeting cards and informational materials. This is a minor revenue stream that also supports the organization's mission.
- Event participation fees: Fees charged for participation in conferences, symposiums, workshops, and educational events. Examples include the SMA-Symposium (€125-175 for members, €175-60 for youth), Col-VI-Fachtagung (€125-190), and DGM THERAPIEWISSEN KOMPAKT seminars (€20-40).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Standard membership (annual fee) |
| Transaction based/ take rate | Multi-year contract | SMA-Symposium 2026 (3 nights, full board) |
| Transaction based/ take rate | Multi-year contract | Col-VI-MD-Fachtagung 2026 (2 nights) |
| Transaction based/ take rate | Pay-as-you-go | DGM THERAPIEWISSEN KOMPAKT (Online seminar) |
| Transaction based/ take rate | Multi-year contract | FSHD-Patiententage 2026 (2 nights) |
| Transaction based/ take rate | Multi-year contract | 28. DGM-Kongress 2027 |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels8 records
DGM product offering
Product offeringCore offering
DGM is Germany's largest nonprofit self-help organization for people with neuromuscular diseases, operating a member-based support ecosystem. It delivers social and assistive-device counseling, diagnosis-specific and regional support groups, professional training seminars, an annual medical congress, research funding and prizes, and community resources spanning over 100 neuromuscular conditions including ALS, SMA, Duchenne/Becker muscular dystrophy, CMT, and FSHD.
Product overview
DGM operates as a comprehensive self-help organization platform for people with neuromuscular diseases. The core offering consists of a multi-channel information and support ecosystem including the main website with disease information, a shop for greeting cards and materials, the DGM Forum for peer exchange, a quarterly newsletter, the DGM Kongress (annual medical congress), and the JungeDGM youth division. The organization also provides specialized services like DGM THERAPIEWISSEN KOMPAKT (professional training webinars) and the DGM Patientenlotse (patient guide service), all coordinated through 16 regional state associations and 12 diagnosis-specific groups covering conditions like ALS, SMA, DMD/BMD, CMT, and others.
Differentiator
Problem solved
Functional benefit
Products and services
- DGM Annual Membership Recurring annual subscription for individuals with neuromuscular diseases and their families, granting access to social counseling, assistive-device consultation, local self-help groups, diagnosis-specific communities, conferences, the DGM-Forum, and the quarterly DGM newsletter.
- DGM Shop E-commerce storefront offering greeting cards and informational materials for supporters of people affected by muscular diseases, supporting the organization's mission as a minor revenue stream.
- DGM THERAPIEWISSEN KOMPAKT Online continuing-education seminar series for physiotherapists, occupational therapists, and speech-language therapists treating neuromuscular conditions, with tiered pricing for DGM members, members of professional associations (DVE, dbl, Physio Deutschland), and non-members.
- DGM Kongress Annual medical congress bringing together national and international experts in neuropediatrics, neurology, neuropathology, genetics, and rehabilitation medicine; the event hosts the presentation of research prizes including the Duchenne-Erb-Preis, Felix-Jerusalem-Preis, Junior-Preis, and Myositis-Nachwuchs-Forschungspreis.
- SMA-Symposium Diagnosis-specific residential symposium for patients with spinal muscular atrophy (SMA) and their families, featuring tiered pricing for DGM members, non-members, youth (13+), and free for children (0-12).
- Col-VI-MD-Fachtagung Specialist conference for Collagen VI muscular dystrophy patients and families featuring tiered pricing for members, non-members, and youth, with a hybrid in-person and online participation option.
- FSHD-Patiententage Patient days for FSHD (facioscapulohumeral muscular dystrophy) including the awarding of the FSHD-Ulrich-Brodeßer-Forschungspreise research prize for outstanding contributions to FSHD research.
Quantifiable outcome
- More than 100,000 people in Germany affected by neuromuscular diseases served
Companies that use DGM
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
DGM technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
DGM partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- twingle GmbHcoretwingle GmbH (Prinzenallee 74, 13357 Berlin) provides the technical platform for DGM's donation processing system. The company stores donation data on servers in Germany and DGM has a data processing agreement with twingle in accordance with GDPR requirements.
- PayPalcorePayPal is integrated as a payment processor for DGM's donation system, allowing donors to make secure online payments. PayPal handles payment information and transaction processing while DGM stores donor details for issuing donation receipts.
- Hetzner Online GmbHcoreHetzner (Industriestr. 25, 91710 Gunzenhausen) provides web hosting services for DGM's website and online platforms.
- Ecoplan GmbHcoreEcoplan GmbH (Justus-Liebig-Straße 6, 36093 Künzell) is the contractor for DGM's CRM system development and maintenance under Art. 28 GDPR data processing agreements.
- BiogenminorBiogen is a pharmaceutical sponsor for the SMA-Symposium 2026, supporting the event financially in exchange for association with the event.
- NovartisminorNovartis is a pharmaceutical sponsor for the SMA-Symposium 2026, supporting the event financially.
- Scholar RockminorScholar Rock is a pharmaceutical sponsor for the SMA-Symposium 2026, supporting the event financially.
- RocheminorRoche is a pharmaceutical sponsor for the SMA-Symposium 2026, supporting the event financially.
- Hotel Franz (Essen)minorHotel Franz in Essen is a recurring venue for DGM NRW regional events including member weekends and Tag der Muskelkranken meetings.
- Neuromuskuläre Zentren (Neuromuscular Centers)coreDGM works with a network of specialized neuromuscular centers throughout Germany for diagnosis, treatment, and research collaboration.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
DGM competitors and assessment
Company assessmentDirect peers
- NORD (National Organization for Rare Disorders): US-based rare disease umbrella patient advocacy organization operating a similar multi-stakeholder model (patient organizations, research, advocacy, education) with comparable funding mix (memberships, donations, corporate partnerships). Useful global comparable for organizational scale benchmarking.
- Muscular Dystrophy Association (MDA): Direct global peer — the leading US neuromuscular disease patient advocacy organization providing disease information, research funding, clinical care referrals, and community support. Highly comparable in mission, structure (multi-disease umbrella), and revenue model (memberships, donations, sponsored events) to DGM, though operating at much larger scale and across the US.
- Cure SMA: Direct peer — leading US-based SMA patient advocacy organization. Highly relevant given that DGM's SMA-Symposium is its flagship pharma-sponsored event; both organizations occupy the SMA patient-advocacy niche and compete for similar pharma partnerships and donor dollars.
- ACHSE (Allianz Chronischer Seltener Erkrankungen): German umbrella alliance of patient organizations for chronic rare diseases; DGM is a member-type counterpart. Directly comparable as a coordinating body for rare disease advocacy, policy engagement, and patient navigation support in Germany.
- ALS Association: Direct disease-specific peer — the largest US nonprofit dedicated to ALS research, care services, and advocacy. Operates with a similar model (chapters, support groups, research grants, advocacy) and serves a population that overlaps with one of DGM's 12+ diagnosis-specific groups, making the operating playbook highly transferable.
- EURORDIS – Rare Diseases Europe: European umbrella alliance for rare disease patient organizations, of which DGM is a member-type counterpart. Directly comparable as a federation convening disease-specific patient groups across Europe for advocacy, policy, and research funding purposes.
- Treat-NMD: European neuromuscular disease research network and advocacy alliance. Directly comparable as a neuromuscular-specific organization coordinating across academic, clinical, industry, and patient stakeholders for translational research and care standards — overlapping mission with DGM's research funding and congress activities.
- Deutsche Multiple Sklerose Gesellschaft (DMSG): The leading German patient advocacy organization for multiple sclerosis, structurally nearly identical to DGM — German nonprofit, membership-based, 16 regional state associations, professional counseling, research funding, pharma partnerships. Closest German structural and operational peer.
Regional players
- Muskelkrank & Forschung (Swiss neuromuscular patient org equivalents, e.g., Schweizerische Muskelgesellschaft): Swiss counterpart patient organization for neuromuscular diseases. Operates the same essential model (counseling, support groups, research funding, member services) in a neighboring jurisdiction, providing a comparable operating scale and structure for benchmarking.
- Deutsche Gesellschaft für Parkinson und Bewegungsstörungen (dPV / Parkinson-Netzwerke): Another leading German disease-specific patient self-help organization with similar structure (federal headquarters, regional associations, support groups, research funding). Strong German regional peer for benchmarking operating model and scale, though focused on Parkinson's rather than neuromuscular diseases.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
DGM social profiles
Digital presenceDGM financial estimates
Financial estimateRevenue estimate
Valuation estimate
DGM leadership team
Management profileNumber of profiles
Profiles1 record
DGM funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DGM M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DGM
What does DGM do?
DGM is Germany's largest nonprofit self-help organization for people with neuromuscular diseases, operating a member-based support ecosystem. It delivers social and assistive-device counseling, diagnosis-specific and regional support groups, professional training seminars, an annual medical congress, research funding and prizes, and community resources spanning over 100 neuromuscular conditions including ALS, SMA, Duchenne/Becker muscular dystrophy, CMT, and FSHD.
Is DGM a public or private company?
DGM is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was DGM founded?
DGM was founded in 2004. It employs 11 to 50 people.
Where is DGM based?
DGM is headquartered in Freiburg, Germany, in the Europe region.
How does DGM make money?
Four revenue lines are on record. Membership dues are the primary driver. The others are donations and charitable contributions, shop sales and event participation fees.
Who are DGM's main competitors?
Direct peers on record are NORD (National Organization for Rare Disorders), Muscular Dystrophy Association (MDA), Cure SMA, ACHSE (Allianz Chronischer Seltener Erkrankungen), ALS Association, EURORDIS – Rare Diseases Europe, Treat-NMD and Deutsche Multiple Sklerose Gesellschaft (DMSG). Regional players are Muskelkrank & Forschung (Swiss neuromuscular patient org equivalents, e.g., Schweizerische Muskelgesellschaft) and Deutsche Gesellschaft für Parkinson und Bewegungsstörungen (dPV / Parkinson-Netzwerke).
Does DGM have an API?
No public API is recorded for DGM.
What industry is DGM in?
DGM's product category is Patient Advocacy and Self-Help Services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8300.